| CIUEX | VEURX | CIUEX / VEURX | |
| Total Expense Ratio | 0.08 | 0.24 | 33% |
| Annual Report Gross Expense Ratio | 0.28 | 0.24 | 117% |
| Fund Existence | 7 years | 36 years | - |
| Gain YTD | 30.019 | 31.029 | 97% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 19B | 35.8B | 53% |
| Annual Yield % from dividends | 2.51 | 2.71 | 93% |
| Returns for 1 year | 25.08 | 24.80 | 101% |
| Returns for 3 years | 55.69 | 47.22 | 118% |
| Returns for 5 years | 59.71 | 41.80 | 143% |
| Returns for 10 years | N/A | 74.88 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DFSV | 34.10 | 0.28 | +0.83% |
| Dimensional US Small Cap Value ETF | |||
| BSJS | 22.04 | 0.02 | +0.09% |
| Invesco BulletShares 2028 HY Corp Bd ETF | |||
| IDNA | 26.69 | 0.01 | +0.04% |
| iShares Genomics Immnlgy & Hlthcr ETF | |||
| TPLE | 27.74 | N/A | N/A |
| Timothy Plan US Large/Mid CAP Core Enhanced ETF | |||
| EMOT | 24.21 | N/A | N/A |
| First Trust S&P 500 Economic Moat ETF | |||